Immuneering Corporation
IMRX • NASDAQ
Immuneering Corporation is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Benjamin J. Zeskind, with a market cap of $320.7M.
CEOBenjamin J. Zeskind
Next Earnings
Upcoming earnings announcement for Immuneering Corporation
Date
Monday, May 4, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.27
Earnings History
Past 12 earnings reports for Immuneering Corporation
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 6, 2026 | Q4 2025 | -$0.18Est: -$0.31 | +41.9% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.38Est: -$0.38 | 0.0% | - | — | 10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.40Est: -$0.40 | 0.0% | - | — | 10-Q |
| May 5, 2025 | Q1 2025 | -$0.42Est: -$0.58 | +27.6% | - | — | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.58Est: -$0.47 | -23.4% | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.49Est: -$0.55 | +10.9% | - | — | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.47Est: -$0.52 | +9.6% | - | — | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.49Est: -$0.46 | -6.5% | - | — | 10-Q |
| Mar 1, 2024 | Q4 2023 | -$0.52Est: -$0.47 | -10.6% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.43Est: -$0.49 | +12.2% | - | — | — |
| Aug 3, 2023 | Q2 2023 | -$0.43Est: -$0.53 | +18.9% | - | — | 10-Q |
| May 4, 2023 | Q1 2023 | -$0.51Est: -$0.56 | +8.9% | -Est: $10.0K | -100.0% | — |